NO885360L - Diagnose av sterk fedme foraarsaket av genetisk abnormalitet og fremgangsmaate for terapeutisk behandling av genetiskforaarsaket fedme. - Google Patents

Diagnose av sterk fedme foraarsaket av genetisk abnormalitet og fremgangsmaate for terapeutisk behandling av genetiskforaarsaket fedme.

Info

Publication number
NO885360L
NO885360L NO88885360A NO885360A NO885360L NO 885360 L NO885360 L NO 885360L NO 88885360 A NO88885360 A NO 88885360A NO 885360 A NO885360 A NO 885360A NO 885360 L NO885360 L NO 885360L
Authority
NO
Norway
Prior art keywords
obedience
caused
genetic
diagnosis
strong
Prior art date
Application number
NO88885360A
Other languages
English (en)
Norwegian (no)
Other versions
NO885360D0 (no
Inventor
Jeffrey S Flier
Bruce M Spiegelman
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of NO885360D0 publication Critical patent/NO885360D0/no
Publication of NO885360L publication Critical patent/NO885360L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO88885360A 1987-04-02 1988-12-01 Diagnose av sterk fedme foraarsaket av genetisk abnormalitet og fremgangsmaate for terapeutisk behandling av genetiskforaarsaket fedme. NO885360L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3420387A 1987-04-02 1987-04-02
PCT/US1988/000999 WO1988007681A1 (en) 1987-04-02 1988-03-29 Diagnosing obesity caused by a genetic abnormality and method of therapeutically treating genetically caused obesity

Publications (2)

Publication Number Publication Date
NO885360D0 NO885360D0 (no) 1988-12-01
NO885360L true NO885360L (no) 1989-02-01

Family

ID=21874944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885360A NO885360L (no) 1987-04-02 1988-12-01 Diagnose av sterk fedme foraarsaket av genetisk abnormalitet og fremgangsmaate for terapeutisk behandling av genetiskforaarsaket fedme.

Country Status (13)

Country Link
EP (2) EP0382720B1 (xx)
JP (1) JPH02503229A (xx)
AT (1) ATE80465T1 (xx)
AU (1) AU606946B2 (xx)
DE (1) DE3874543T2 (xx)
DK (1) DK675388D0 (xx)
ES (1) ES2046325T3 (xx)
FI (1) FI894592A (xx)
GR (1) GR3005716T3 (xx)
IL (1) IL85897A0 (xx)
NO (1) NO885360L (xx)
WO (1) WO1988007681A1 (xx)
ZA (1) ZA882288B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8087591A (en) * 1990-06-01 1991-12-31 W. Alton Jones Cell Science Center Mammalian adipogenic factors
EP1578367A4 (en) * 2002-11-01 2012-05-02 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
WO2015138309A1 (en) 2014-03-13 2015-09-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for regulating pancreatic beta cell function using adipsin
DE102014107380A1 (de) 2014-05-26 2015-11-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür

Also Published As

Publication number Publication date
NO885360D0 (no) 1988-12-01
EP0382720A1 (en) 1990-08-22
EP0287509B1 (en) 1992-09-16
AU606946B2 (en) 1991-02-21
EP0287509A1 (en) 1988-10-19
ATE80465T1 (de) 1992-09-15
EP0382720A4 (en) 1991-01-02
DK675388A (da) 1988-12-02
IL85897A0 (en) 1988-09-30
DK675388D0 (da) 1988-12-02
DE3874543D1 (de) 1992-10-15
JPH02503229A (ja) 1990-10-04
WO1988007681A1 (en) 1988-10-06
DE3874543T2 (de) 1993-02-04
AU1591388A (en) 1988-11-02
EP0382720B1 (en) 1992-09-09
ES2046325T3 (es) 1994-02-01
FI894592A0 (fi) 1989-09-28
FI894592A (fi) 1989-09-28
ZA882288B (en) 1988-12-28
GR3005716T3 (xx) 1993-06-07

Similar Documents

Publication Publication Date Title
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
EP0376251A3 (en) An anticoagulant substance obtained from urine
NO885360D0 (no) Diagnose av sterk fedme foraarsaket av genetisk abnormalitet og fremgangsmaate for terapeutisk behandling av genetisk foraarsaket fedme.
Ryder et al. Serum angiotensin converting enzyme activity in patients with psoriasis
Scharf et al. Transverse myelitis with systemic lupus erythematosus
Leisti et al. Phenotypic variation in alpha-L-iduronidase deficiency
SU943578A1 (ru) Способ определени суточной дозы гепарина
Beamish et al. Ondine's curse after carotid endarterectomy.
Nanra et al. The use of trimethoprim and sulphamethoxazole in the management of chronic and recurrent upper and lower urinary tract infection
SU787995A1 (ru) Способ дифференцировани т и в лимфоцитов человека
DE3572033D1 (en) Method for diagnosis of a.i.d.s.
Neuman et al. Hepatotoxicity of hornet's venom sac extract in isolated perfused rat liver
Smith The Interpretation of Plasma Haloperidol Concentrations-Reply
Kaipainen et al. Clinical study of bacampicillin in urinary tract infections—a comparison with ampicillin
Owen Entamoeba histolytica in inbred mice: evidence of liver involvement
SU1405842A1 (ru) Способ лечени печеночных заболеваний
London et al. On the potential enzymatic control of uric acid metabolism
KRANTZ A TWIN STUDY OF NEUROPSYCHOLOGICAL ABILITIES (LEARNING DISABILITIES, HALSTEAD-REITAN)
Bergmann et al. Pharmacological study of a new antibiotic of bacillary origin
Chandra et al. 691 IMMUNOCOMPETENCE IN OBESITY
Milovanovié et al. Urinary 5hydroxyindoleacetic acid and serum phenobarbital of children suffering from epilepsy
KR890005277A (ko) 2본쇄 rna 부족 상태의 진단 및 치료방법
Manger et al. Cimetidine and psoriatic arthritis
Korczyn et al. Transient Neurogenic Urinary Retention
Djojosoebagio et al. Effect of sodium citrate on milk yield in rats.